Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214623
Company: FRESENIUS KABI USA
Company: FRESENIUS KABI USA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CARDIOPLEGIC IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | SOLUTION;PERFUSION, CARDIAC | Prescription | AT | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/18/2022 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
CARDIOPLEGIC IN PLASTIC CONTAINER
SOLUTION;PERFUSION, CARDIAC; 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
CARDIOPLEGIC IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | SOLUTION;PERFUSION, CARDIAC | Prescription | No | AT | 075323 | BAXTER HLTHCARE |
CARDIOPLEGIC IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | SOLUTION;PERFUSION, CARDIAC | Prescription | No | AT | 214623 | FRESENIUS KABI USA |
PLEGISOL IN PLASTIC CONTAINER | CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE | 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML | SOLUTION;PERFUSION, CARDIAC | Prescription | Yes | AT | 018608 | HOSPIRA |